Helsinn Group is a renowned pharmaceutical brand that has been dedicated to improving the lives of cancer patients for over 40 years. Initially founded as a pharmaceutical licensing business, Helsinn Group has evolved to become a global leader in the oncology and rare disease field. With a team of committed employees and strong partnerships with commercial and marketing partners, Helsinn Group has built an extensive portfolio of late-and commercial-stage oncology and rare disease products.

They are focused on delivering life-changing treatments for people with cancer today and in the future. Headquartered in Lugano, Switzerland, Helsinn Group operates world-class production facilities in Dublin, Ireland, showcasing their commitment to quality. They also have a growing presence in the United States and China.

Guided by their core values of respect, integrity, and quality, Helsinn Group is dedicated to extending the reach of their quality care and fulfilling unmet needs for people with cancer worldwide. They strive to build better today for every person affected by cancer